Featured Jobs
|
Daybright Financial
|
|
Senior Plan Consultant, Defined Benefit DWC - The 401(k) Experts
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
|
Retirement Relationship Manager MAP Retirement
|
|
Senior Plan Consultant, Defined Benefit DWC - The 401(k) Experts
|
|
Regional Vice President, Sales MAP Retirement
|
|
MAP Retirement
|
|
MAP Retirement
|
|
Senior Counsel â Investment Solutions Great Gray Trust Company
|
|
The MandMarblestone Group, llc
|
|
MAP Retirement
|
|
Relationship Manager - Actuary Daybright Financial
|
|
The Pension Source
|
|
Senior Retirement Plan Administrator (TPA) Public Accounting Firm
|
|
Goldberg, Swedelson & Associates
|
|
Plan Admin/Employee Benefits/Office Admin Columbia Benefits, LLC
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Press Releases by Date | Press Releases by Company Name
View More Press Releases by EBRI [Employee Benefit Research Institute]
|
Press Release EBRI Welcomes New Retirement Vice Chair, Jason Jagatic |
|
Issued by EBRI [Employee Benefit Research Institute] Sept. 30, 2021 |
|
Please welcome Jason Jagatic, CFP, head of Global and Workplace Thought Leadership for Fidelity Investments, as EBRI’s new Research Committee Vice Chair for Retirement. He replaces Bob Macdonald, who retired after many years of EBRI volunteer service. Jason joined Fidelity in July 2006 and has held numerous management roles in Fidelity’s retail and workplace businesses. He was responsible for development of many of Fidelity’s retirement and investing tools used by both individual investors and Fidelity representatives and was a leader in the Fidelity Wealth Management business. He is a Certified Financial Planner™ who holds his Series 7 & 24 licenses as well as multiple patents. |
View More Press Releases by EBRI [Employee Benefit Research Institute]
|
Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink. |